Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 11

Abstract

ABSTRACT Introduction: Creatine Kinase (CK), a key enzyme of cellular energy metabolism helps the cells to function under high demands by involving in contractile processes and active trans-membrane transport by readily providing Adenosine-5’-triphosphate (ATP). Higher CK activity increases cardiovascular trophic responses and development of arterial hypertension. Hence, high CK activity may increase hypertension risk and may also be a cause behind the hypertensive treatment failure. Aim: In the present study, serum CK levels are compared between hypertensive and normotensive study subjects and association of serum CK in hypertensive treatment failure cases. Materials and Methods: A total of 75 known hypertensive patients who were under antihypertensive treatment for ≥3 months were taken as cases. Further grouping of the patients was done based upon the response to antihypertensive treatment into treatment control (n=40) and without treatment control (n=35) groups. Forty individuals age and sex matched normotensive control were taken. Serum Creatine Kinase, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, was measured in the study group. Kruskal Wallis test was done to compare the parameters in all the three study groups. Correlation of serum CK with other parameters was done. Cut-Off value for serum CK was calculated in hypertensive cases. Results: CK was found to be higher in hypertensive cases with treatment control (99.55±31.34) U/L compared to normotensives (72.66±25.42) U/L. Significantly higher CK level was found in hypertensive treatment failures (313.92±133.12) U/L compared to treatment control cases. Statistically significant correlation was found between serum CK with SBP and DBP in hypertensive treatment failure cases. A cut-off value of 168.5 U/L was found out in hypertensive patients. Conclusion: Serum CK was found to be associated with severity of blood pressure and failure of antihypertensive therapy.

Authors and Affiliations

Surankita Sukul, Jyotirmayee Bahinipati, Saurav Patra, Kandasamy Ravichandran

Keywords

Related Articles

Non Alcoholic Fatty Liver Disease: Problems in Perception and Solution

ABSTRACT Non Alcoholic Fatty Liver Disease (NAFLD) is now being recognised as a healthcare burden in India and abroad. An inevitable increase in its incidence is expected in future, presenting before the physicians a lar...

Financial Burden of Out-of-Pocket Expenditures for Primary Health Care in Hilly Areas of Garhwal Region, Uttarakhand, North India

Introduction: High total health expenditures via Out-of-Pocket (OOP) as formal user fees and informal payments put India in challenging situation to achieve towards universal health coverage. Aim: To assess the (OOP) exp...

Large Eccrine Acrospiroma of the Hand

Eccrine acrospiroma are benign skin tumours of sweat duct origin. They usually present as small solid or cystic lesions which are confused clinically with other solid or cystic lesions. These are generally benign lesions...

Burkholderia Infections in Diabetic Patients Emerging as a Challenge for Physicians: A Case Series

A BSTRACT The genus Burkholderia comprises more than 40 species. Medically important members of this genus are Burkholderia cepacia (B.cepacia), Burkholderia pseudomallei (B.pseudomallei) and Burkholderia mallei (B.malle...

Histopathological Study of Central Nervous System Lesions: Emphasizing Association of Neoplasms with ABO Blood Groups

Introduction: The Central Nervous System (CNS) lesions show considerable geographic and racial variations with respect to the incidence and the pattern of distribution of lesions. The ABO blood status is a readily access...

Download PDF file
  • EP ID EP524388
  • DOI 10.7860/JCDR/2018/36908.12284
  • Views 52
  • Downloads 0

How To Cite

Surankita Sukul, Jyotirmayee Bahinipati, Saurav Patra, Kandasamy Ravichandran (2018). Serum Creatine Kinase Activity among Hypertensive Patients and its Role as a Predictor for Failure of Antihypertensive Treatment. Journal of Clinical and Diagnostic Research, 12(11), 19-22. https://europub.co.uk/articles/-A-524388